TREATMENTS › MEDICAL THERAPY
Medical Therapy — The Medicines That Protect Your Heart, Brain & Limbs
Opening a blocked artery is only half the job. The right blood-thinning medicines — taken consistently — are what keep arteries and stents open and lower your risk of heart attack, stroke, clots, and limb loss. We tailor them to you and manage them alongside your other doctors.
Why medicine is part of the treatment — not an afterthought
Antiplatelet and anticoagulant medications (often called “blood thinners”) are a core part of cardiovascular and vascular care. They protect the results of a procedure and, on their own, prevent many heart attacks, strokes, and amputations. The goal is the right medicine, at the right intensity, taken consistently — balanced carefully against bleeding risk.
What the evidence shows
Antiplatelet therapy — keeping arteries and stents open
Antiplatelet medicines make platelets less “sticky,” lowering the risk of clots in arteries and stents. They are central to treating peripheral artery disease and coronary disease.
-
Single antiplatelet therapy — low-dose aspirin or clopidogrel for symptomatic PAD and coronary disease.
-
Dual-pathway therapy — adding low-dose rivaroxaban to aspirin reduces both cardiovascular events and limb events in PAD (COMPASS, VOYAGER PAD); it is the only regimen shown to prevent both after lower-extremity revascularization.
-
Dual antiplatelet therapy (DAPT) after a stent — aspirin plus a second agent (clopidogrel, ticagrelor, or prasugrel) for a defined period. After a coronary stent, typically about 6 months for stable disease and at least 12 months after a heart attack. After a leg artery stent the duration is usually shorter and is set case by case. Your physician sets yours; never stop early on your own.
Peripheral Artery Disease → Coronary Artery Disease → IVUS-guided artery treatment →
Anticoagulation — preventing strokes and dangerous clots
Anticoagulants work deeper in the clotting system and are used when the risk is a forming clot — atrial fibrillation, deep vein thrombosis (DVT), or pulmonary embolism.
-
Atrial fibrillation — for most patients, a direct oral anticoagulant (DOAC) such as apixaban, rivaroxaban, edoxaban, or dabigatran is preferred over warfarin. We use the CHA₂DS₂-VASc score to decide who benefits. Importantly, aspirin alone is not adequate stroke protection in AFib.
-
DVT & pulmonary embolism — DOACs are first-line; how long you stay on treatment depends on whether the clot was provoked by a temporary cause or unprovoked.
-
Warfarin still has specific roles, such as mechanical heart valves or rheumatic mitral stenosis.
Heart Rhythm Disorders → Superficial Venous Disease → Cardioversion →
Why taking them exactly as prescribed matters
These medicines only work while they are in your system. Stopping early — or missing doses — is one of the most preventable causes of serious harm:
-
Stopping antiplatelet therapy too soon after a stent is a leading trigger for a clot inside the stent, which is a life-threatening emergency — and it can happen within days.
-
Skipping anticoagulation in atrial fibrillation leaves you exposed to a stroke.
-
Stopping antithrombotic therapy after a leg procedure raises the risk of re-blockage and amputation.
If a medication is too expensive, causes side effects, or feels like too much — tell us. Do not stop on your own. There are almost always alternatives, assistance programs, and adjustments that keep you protected.
How we manage your medical therapy
We individualize your regimen to your specific conditions and your bleeding risk, and we re-check it over time as your situation changes. When you see more than one physician — cardiology, primary care, nephrology — we coordinate so your plan is consistent and safe. For care we don't provide ourselves (such as ablation, valve procedures, or bypass surgery), we stay involved: we help select the right specialist for your situation, align your medications around the procedure, and manage your follow-up. We direct the plan; we don’t hand it off.
For Referring Providers →
Frequently asked questions
For referring providers — We co-manage antithrombotic therapy and welcome complex cases — including patients with overlapping indications such as atrial fibrillation plus a recent coronary stent, where balancing clot and bleeding risk takes careful coordination. Refer: (918) 943-5303 · fax (855) 312-3594